These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9404419)

  • 1. [Bosentan attenuates the hypertensive effect of angiotensin II in rats].
    Herizi A; Jover B; Mimran A
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1117-20. PubMed ID: 9404419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat.
    Ficai S; Herizi A; Mimran A; Jover B
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1100-3. PubMed ID: 11903325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade.
    Herizi A; Jover B; Bouriquet N; Mimran A
    Hypertension; 1998 Jan; 31(1):10-4. PubMed ID: 9449383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan].
    Herizi A; Belabbas H; Mimran A; Jover B
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):983-6. PubMed ID: 10989742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin mediates some of the renal actions of acutely administered angiotensin II.
    Riggleman A; Harvey J; Baylis C
    Hypertension; 2001 Jul; 38(1):105-9. PubMed ID: 11463769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of AT2 receptors in the cardiovascular events following microinjection of angiotensin II into the superior colliculus of anaesthetised rats.
    D'Amico M; Di Filippo C; Rossi F; Warner TD
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):121-5. PubMed ID: 9521484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide in regional blood flow in angiotensin II-induced hypertensive rats.
    Nishiyama A; Fujisawa Y; Fukui T; Rahman M; Kondo N; Ogawa Y; Fanzhu L; Guoxing Z; Kimura S; Abe Y
    Hypertens Res; 2001 Jul; 24(4):421-7. PubMed ID: 11510755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat.
    Kramp R; Fourmanoir P; Caron N
    Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1132-40. PubMed ID: 11704565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan prevents preglomerular alterations during angiotensin II hypertension.
    Casellas D; Bouriquet N; Herizi A
    Hypertension; 1997 Dec; 30(6):1613-20. PubMed ID: 9403591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ; Blaschak CM; Chinoy MR; Jackson EK
    Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
    Richard V; Hogie M; Thuillez C
    Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
    Cervenka L; Navar LG
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats.
    Kondo N; Kiyomoto H; Yamamoto T; Miyatake A; Sun GP; Rahman M; Hitomi H; Moriwaki K; Hara T; Kimura S; Abe Y; Kohno M; Nishiyama A
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1047-52. PubMed ID: 16319305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II and endothelin-1 receptor antagonists have cumulative hypotensive effects in canine Page hypertension.
    Massart PE; Hodeige DG; Van Mechelen H; Charlier AA; Ketelslegers JM; Heyndrickx GR; Donckier JE
    J Hypertens; 1998 Jun; 16(6):835-41. PubMed ID: 9663924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
    Inscho EW; Imig JD; Deichmann PC; Cook AK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.
    Stevens EJ; Tomlinson DR
    Br J Pharmacol; 1995 May; 115(2):373-9. PubMed ID: 7670740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
    Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.